Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Phaos Technology Holdings CaymanPOAS 4 Days Sales Outstanding is 88.57 as of Oct. 2025, which is 71% below its 10-year median of 306.78. GuruFocus rates POAS with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks worse than 63.95% on this metric.
The historical rank and industry rank for Phaos Technology Holdings Cayman's Days Sales Outstanding or its related term are showing as below:
POAS'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.97 Med: 306.78 Max: 478.52
Current: 76.97
During the past 3 years, Phaos Technology Holdings Cayman's highest Days Sales Outstanding was 478.52. The lowest was 76.97. And the median was 306.78.
POAS's Days Sales Outstanding is ranked worse than 63.95% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.21
vs POAS: 76.97
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phaos Technology Holdings Cayman Days Sales Outstanding Chart
POAS vs XAIR, LUDG, TNON: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Phaos Technology Holdings Cayman's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phaos Technology Holdings Cayman Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Phaos Technology Holdings Cayman's Days Sales Outstanding falls into.
Phaos Technology Holdings Cayman Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phaos Technology Holdings Cayman (POAS) has a Days Sales Outstanding of 88.57 as of Oct. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Phaos Technology Holdings Cayman and its competitors. This is 71% below median its historical median of 306.78. Over the past decade, Phaos Technology Holdings Cayman's Days Sales Outstanding has ranged from 76.97 to 478.52. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #518 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 64%.
Is Phaos Technology Holdings Cayman's Days Sales Outstanding too high?
Phaos Technology Holdings Cayman's current Days Sales Outstanding of 88.57 is 71% below median its 10-year median of 306.78. Over the past 10 years, this metric has ranged from a low of 76.97 to a high of 478.52. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.21. Phaos Technology Holdings Cayman's value of 88.57 is 35.8% above this industry median. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #518 out of 810 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's Days Sales Outstanding compare to XAIR and LUDG?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #518 out of 810 companies for Days Sales Outstanding. This places Phaos Technology Holdings Cayman in the lower half of its industry. The industry median Days Sales Outstanding is 65.21. Phaos Technology Holdings Cayman's value of 88.57 is 35.8% above this benchmark. Historically, Phaos Technology Holdings Cayman's own Days Sales Outstanding has ranged from 76.97 to 478.52 over the past decade. While the company's 10-year median is 306.78 vs. the industry median of 65.21, Phaos Technology Holdings Cayman has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.21, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phaos Technology Holdings Cayman's current Days Sales Outstanding of 88.57 is 35.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Phaos Technology Holdings Cayman and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current Days Sales Outstanding is 88.57, which is 71% below median its own 10-year median of 306.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current Days Sales Outstanding of 88.57. The current Days Sales Outstanding is 88.57, which is 71% below median its 10-year median of 306.78 and 35.8% above the Medical Devices & Instruments industry median of 65.21. Phaos Technology Holdings Cayman's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current Days Sales Outstanding is 88.57 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
4GF Score
Get the complete analysis for POAS
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POAS has been successfully added to your 
